nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR2B—Sorafenib—kidney cancer	0.172	0.606	CbGbCtD
Methysergide—HTR2C—Sorafenib—kidney cancer	0.112	0.394	CbGbCtD
Methysergide—Feeling abnormal—Everolimus—kidney cancer	0.00151	0.00212	CcSEcCtD
Methysergide—Gastrointestinal pain—Vinblastine—kidney cancer	0.00151	0.00211	CcSEcCtD
Methysergide—Thrombocytopenia—Sunitinib—kidney cancer	0.0015	0.0021	CcSEcCtD
Methysergide—Gastrointestinal pain—Everolimus—kidney cancer	0.0015	0.0021	CcSEcCtD
Methysergide—Discomfort—Dactinomycin—kidney cancer	0.0015	0.0021	CcSEcCtD
Methysergide—Vomiting—Pazopanib—kidney cancer	0.00148	0.00207	CcSEcCtD
Methysergide—Rash—Pazopanib—kidney cancer	0.00147	0.00206	CcSEcCtD
Methysergide—Nausea—Temsirolimus—kidney cancer	0.00147	0.00206	CcSEcCtD
Methysergide—Dermatitis—Pazopanib—kidney cancer	0.00147	0.00205	CcSEcCtD
Methysergide—Back pain—Gemcitabine—kidney cancer	0.00146	0.00204	CcSEcCtD
Methysergide—Abdominal pain—Vinblastine—kidney cancer	0.00146	0.00204	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00145	0.00204	CcSEcCtD
Methysergide—Oedema—Dactinomycin—kidney cancer	0.00145	0.00204	CcSEcCtD
Methysergide—Abdominal pain—Everolimus—kidney cancer	0.00145	0.00203	CcSEcCtD
Methysergide—Body temperature increased—Everolimus—kidney cancer	0.00145	0.00203	CcSEcCtD
Methysergide—Gastrointestinal pain—Erlotinib—kidney cancer	0.00145	0.00203	CcSEcCtD
Methysergide—Blood urea increased—Doxorubicin—kidney cancer	0.00144	0.00202	CcSEcCtD
Methysergide—Oedema peripheral—Paclitaxel—kidney cancer	0.00143	0.002	CcSEcCtD
Methysergide—Thrombocytopenia—Dactinomycin—kidney cancer	0.00142	0.00199	CcSEcCtD
Methysergide—Dyspnoea—Sorafenib—kidney cancer	0.00142	0.00199	CcSEcCtD
Methysergide—Dyspepsia—Sorafenib—kidney cancer	0.0014	0.00197	CcSEcCtD
Methysergide—Abdominal pain—Erlotinib—kidney cancer	0.0014	0.00196	CcSEcCtD
Methysergide—Body temperature increased—Erlotinib—kidney cancer	0.0014	0.00196	CcSEcCtD
Methysergide—Ill-defined disorder—Gemcitabine—kidney cancer	0.0014	0.00196	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.0014	0.00196	CcSEcCtD
Methysergide—Neutropenia—Capecitabine—kidney cancer	0.00139	0.00195	CcSEcCtD
Methysergide—Dysuria—Capecitabine—kidney cancer	0.00139	0.00195	CcSEcCtD
Methysergide—Insomnia—Sunitinib—kidney cancer	0.00139	0.00194	CcSEcCtD
Methysergide—Nausea—Pazopanib—kidney cancer	0.00138	0.00194	CcSEcCtD
Methysergide—Paraesthesia—Sunitinib—kidney cancer	0.00138	0.00193	CcSEcCtD
Methysergide—Convulsion—Vincristine—kidney cancer	0.00138	0.00193	CcSEcCtD
Methysergide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00138	0.00193	CcSEcCtD
Methysergide—Fatigue—Sorafenib—kidney cancer	0.00138	0.00193	CcSEcCtD
Methysergide—Dyspnoea—Sunitinib—kidney cancer	0.00137	0.00192	CcSEcCtD
Methysergide—Pain—Sorafenib—kidney cancer	0.00136	0.00191	CcSEcCtD
Methysergide—Constipation—Sorafenib—kidney cancer	0.00136	0.00191	CcSEcCtD
Methysergide—Malaise—Gemcitabine—kidney cancer	0.00136	0.00191	CcSEcCtD
Methysergide—Myalgia—Vincristine—kidney cancer	0.00135	0.0019	CcSEcCtD
Methysergide—Weight increased—Capecitabine—kidney cancer	0.00135	0.0019	CcSEcCtD
Methysergide—Dyspepsia—Sunitinib—kidney cancer	0.00135	0.00189	CcSEcCtD
Methysergide—Flushing—Paclitaxel—kidney cancer	0.00135	0.00189	CcSEcCtD
Methysergide—Weight decreased—Capecitabine—kidney cancer	0.00135	0.00189	CcSEcCtD
Methysergide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00133	0.00186	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00132	0.00185	CcSEcCtD
Methysergide—Asthenia—Vinblastine—kidney cancer	0.00132	0.00185	CcSEcCtD
Methysergide—Fatigue—Sunitinib—kidney cancer	0.00132	0.00185	CcSEcCtD
Methysergide—Asthenia—Everolimus—kidney cancer	0.00132	0.00185	CcSEcCtD
Methysergide—Pain—Sunitinib—kidney cancer	0.00131	0.00184	CcSEcCtD
Methysergide—Constipation—Sunitinib—kidney cancer	0.00131	0.00184	CcSEcCtD
Methysergide—Gastrointestinal pain—Sorafenib—kidney cancer	0.0013	0.00183	CcSEcCtD
Methysergide—Oedema—Vincristine—kidney cancer	0.0013	0.00182	CcSEcCtD
Methysergide—Chest pain—Gemcitabine—kidney cancer	0.00129	0.0018	CcSEcCtD
Methysergide—Myalgia—Gemcitabine—kidney cancer	0.00129	0.0018	CcSEcCtD
Methysergide—Arthralgia—Gemcitabine—kidney cancer	0.00129	0.0018	CcSEcCtD
Methysergide—Alopecia—Paclitaxel—kidney cancer	0.00128	0.0018	CcSEcCtD
Methysergide—Thrombophlebitis—Doxorubicin—kidney cancer	0.00128	0.0018	CcSEcCtD
Methysergide—Asthenia—Erlotinib—kidney cancer	0.00127	0.00178	CcSEcCtD
Methysergide—Thrombocytopenia—Vincristine—kidney cancer	0.00127	0.00178	CcSEcCtD
Methysergide—Discomfort—Gemcitabine—kidney cancer	0.00127	0.00178	CcSEcCtD
Methysergide—Diarrhoea—Vinblastine—kidney cancer	0.00126	0.00177	CcSEcCtD
Methysergide—Body temperature increased—Sorafenib—kidney cancer	0.00126	0.00177	CcSEcCtD
Methysergide—Abdominal pain—Sorafenib—kidney cancer	0.00126	0.00177	CcSEcCtD
Methysergide—Diarrhoea—Everolimus—kidney cancer	0.00126	0.00176	CcSEcCtD
Methysergide—Gastrointestinal pain—Sunitinib—kidney cancer	0.00126	0.00176	CcSEcCtD
Methysergide—Fatigue—Dactinomycin—kidney cancer	0.00125	0.00175	CcSEcCtD
Methysergide—Pain—Dactinomycin—kidney cancer	0.00124	0.00174	CcSEcCtD
Methysergide—Oedema—Gemcitabine—kidney cancer	0.00123	0.00172	CcSEcCtD
Methysergide—Back pain—Paclitaxel—kidney cancer	0.00122	0.00171	CcSEcCtD
Methysergide—Dizziness—Vinblastine—kidney cancer	0.00122	0.00171	CcSEcCtD
Methysergide—Dizziness—Everolimus—kidney cancer	0.00122	0.0017	CcSEcCtD
Methysergide—Abdominal pain—Sunitinib—kidney cancer	0.00121	0.0017	CcSEcCtD
Methysergide—Body temperature increased—Sunitinib—kidney cancer	0.00121	0.0017	CcSEcCtD
Methysergide—Diarrhoea—Erlotinib—kidney cancer	0.00121	0.0017	CcSEcCtD
Methysergide—Thrombocytopenia—Gemcitabine—kidney cancer	0.00121	0.00169	CcSEcCtD
Methysergide—Ergonovine—ABCB1—kidney cancer	0.0012	0.475	CrCbGaD
Methysergide—Feeling abnormal—Dactinomycin—kidney cancer	0.0012	0.00168	CcSEcCtD
Methysergide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00119	0.00166	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00118	0.00166	CcSEcCtD
Methysergide—Insomnia—Vincristine—kidney cancer	0.00117	0.00164	CcSEcCtD
Methysergide—Oedema peripheral—Capecitabine—kidney cancer	0.00117	0.00164	CcSEcCtD
Methysergide—Vomiting—Vinblastine—kidney cancer	0.00117	0.00164	CcSEcCtD
Methysergide—Dizziness—Erlotinib—kidney cancer	0.00117	0.00164	CcSEcCtD
Methysergide—Ill-defined disorder—Paclitaxel—kidney cancer	0.00117	0.00164	CcSEcCtD
Methysergide—Vomiting—Everolimus—kidney cancer	0.00117	0.00164	CcSEcCtD
Methysergide—Paraesthesia—Vincristine—kidney cancer	0.00117	0.00163	CcSEcCtD
Methysergide—Rash—Everolimus—kidney cancer	0.00116	0.00162	CcSEcCtD
Methysergide—Dermatitis—Everolimus—kidney cancer	0.00116	0.00162	CcSEcCtD
Methysergide—Abdominal pain—Dactinomycin—kidney cancer	0.00115	0.00161	CcSEcCtD
Methysergide—Body temperature increased—Dactinomycin—kidney cancer	0.00115	0.00161	CcSEcCtD
Methysergide—Asthenia—Sorafenib—kidney cancer	0.00114	0.0016	CcSEcCtD
Methysergide—Malaise—Paclitaxel—kidney cancer	0.00114	0.0016	CcSEcCtD
Methysergide—Vomiting—Erlotinib—kidney cancer	0.00113	0.00158	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00112	0.00157	CcSEcCtD
Methysergide—Gastrointestinal disorder—Vincristine—kidney cancer	0.00112	0.00157	CcSEcCtD
Methysergide—Fatigue—Vincristine—kidney cancer	0.00112	0.00157	CcSEcCtD
Methysergide—Rash—Erlotinib—kidney cancer	0.00112	0.00157	CcSEcCtD
Methysergide—Dermatitis—Erlotinib—kidney cancer	0.00112	0.00156	CcSEcCtD
Methysergide—Insomnia—Gemcitabine—kidney cancer	0.00111	0.00156	CcSEcCtD
Methysergide—Pain—Vincristine—kidney cancer	0.00111	0.00155	CcSEcCtD
Methysergide—Constipation—Vincristine—kidney cancer	0.00111	0.00155	CcSEcCtD
Methysergide—Pain in extremity—Doxorubicin—kidney cancer	0.00111	0.00155	CcSEcCtD
Methysergide—Paraesthesia—Gemcitabine—kidney cancer	0.00111	0.00155	CcSEcCtD
Methysergide—Flushing—Capecitabine—kidney cancer	0.00111	0.00155	CcSEcCtD
Methysergide—Asthenia—Sunitinib—kidney cancer	0.0011	0.00154	CcSEcCtD
Methysergide—Dyspnoea—Gemcitabine—kidney cancer	0.0011	0.00154	CcSEcCtD
Methysergide—Nausea—Vinblastine—kidney cancer	0.0011	0.00153	CcSEcCtD
Methysergide—Somnolence—Gemcitabine—kidney cancer	0.0011	0.00153	CcSEcCtD
Methysergide—Convulsion—Paclitaxel—kidney cancer	0.0011	0.00153	CcSEcCtD
Methysergide—Nausea—Everolimus—kidney cancer	0.00109	0.00153	CcSEcCtD
Methysergide—Diarrhoea—Sorafenib—kidney cancer	0.00109	0.00153	CcSEcCtD
Methysergide—Chest pain—Paclitaxel—kidney cancer	0.00108	0.00151	CcSEcCtD
Methysergide—Arthralgia—Paclitaxel—kidney cancer	0.00108	0.00151	CcSEcCtD
Methysergide—Myalgia—Paclitaxel—kidney cancer	0.00108	0.00151	CcSEcCtD
Methysergide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00106	0.00149	CcSEcCtD
Methysergide—Discomfort—Paclitaxel—kidney cancer	0.00106	0.00149	CcSEcCtD
Methysergide—Fatigue—Gemcitabine—kidney cancer	0.00106	0.00149	CcSEcCtD
Methysergide—Gastrointestinal pain—Vincristine—kidney cancer	0.00106	0.00149	CcSEcCtD
Methysergide—Dizziness—Sorafenib—kidney cancer	0.00106	0.00148	CcSEcCtD
Methysergide—Pain—Gemcitabine—kidney cancer	0.00105	0.00148	CcSEcCtD
Methysergide—Constipation—Gemcitabine—kidney cancer	0.00105	0.00148	CcSEcCtD
Methysergide—Nausea—Erlotinib—kidney cancer	0.00105	0.00148	CcSEcCtD
Methysergide—Alopecia—Capecitabine—kidney cancer	0.00105	0.00147	CcSEcCtD
Methysergide—Diarrhoea—Sunitinib—kidney cancer	0.00105	0.00147	CcSEcCtD
Methysergide—Ataxia—Doxorubicin—kidney cancer	0.00104	0.00146	CcSEcCtD
Methysergide—Asthenia—Dactinomycin—kidney cancer	0.00104	0.00146	CcSEcCtD
Methysergide—Oedema—Paclitaxel—kidney cancer	0.00103	0.00144	CcSEcCtD
Methysergide—Abdominal pain—Vincristine—kidney cancer	0.00103	0.00144	CcSEcCtD
Methysergide—Body temperature increased—Vincristine—kidney cancer	0.00103	0.00144	CcSEcCtD
Methysergide—Dizziness—Sunitinib—kidney cancer	0.00102	0.00142	CcSEcCtD
Methysergide—Feeling abnormal—Gemcitabine—kidney cancer	0.00102	0.00142	CcSEcCtD
Methysergide—Vomiting—Sorafenib—kidney cancer	0.00101	0.00142	CcSEcCtD
Methysergide—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00101	0.00142	CcSEcCtD
Methysergide—Thrombocytopenia—Paclitaxel—kidney cancer	0.00101	0.00141	CcSEcCtD
Methysergide—Tachycardia—Paclitaxel—kidney cancer	0.00101	0.00141	CcSEcCtD
Methysergide—Rash—Sorafenib—kidney cancer	0.00101	0.00141	CcSEcCtD
Methysergide—Dermatitis—Sorafenib—kidney cancer	0.00101	0.00141	CcSEcCtD
Methysergide—Back pain—Capecitabine—kidney cancer	0.001	0.0014	CcSEcCtD
Methysergide—Diarrhoea—Dactinomycin—kidney cancer	0.000995	0.00139	CcSEcCtD
Methysergide—Vomiting—Sunitinib—kidney cancer	0.000976	0.00137	CcSEcCtD
Methysergide—Body temperature increased—Gemcitabine—kidney cancer	0.000974	0.00136	CcSEcCtD
Methysergide—Rash—Sunitinib—kidney cancer	0.000968	0.00136	CcSEcCtD
Methysergide—Dermatitis—Sunitinib—kidney cancer	0.000967	0.00135	CcSEcCtD
Methysergide—Ill-defined disorder—Capecitabine—kidney cancer	0.000962	0.00135	CcSEcCtD
Methysergide—Eosinophilia—Doxorubicin—kidney cancer	0.00095	0.00133	CcSEcCtD
Methysergide—Nausea—Sorafenib—kidney cancer	0.000948	0.00133	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00094	0.00132	CcSEcCtD
Methysergide—Malaise—Capecitabine—kidney cancer	0.000935	0.00131	CcSEcCtD
Methysergide—Insomnia—Paclitaxel—kidney cancer	0.000933	0.00131	CcSEcCtD
Methysergide—Asthenia—Vincristine—kidney cancer	0.000932	0.0013	CcSEcCtD
Methysergide—Paraesthesia—Paclitaxel—kidney cancer	0.000926	0.0013	CcSEcCtD
Methysergide—Vomiting—Dactinomycin—kidney cancer	0.000924	0.00129	CcSEcCtD
Methysergide—Dyspnoea—Paclitaxel—kidney cancer	0.00092	0.00129	CcSEcCtD
Methysergide—Somnolence—Paclitaxel—kidney cancer	0.000917	0.00128	CcSEcCtD
Methysergide—Rash—Dactinomycin—kidney cancer	0.000916	0.00128	CcSEcCtD
Methysergide—Nausea—Sunitinib—kidney cancer	0.000912	0.00128	CcSEcCtD
Methysergide—Dyspepsia—Paclitaxel—kidney cancer	0.000908	0.00127	CcSEcCtD
Methysergide—Dysuria—Doxorubicin—kidney cancer	0.000897	0.00126	CcSEcCtD
Methysergide—Neutropenia—Doxorubicin—kidney cancer	0.000897	0.00126	CcSEcCtD
Methysergide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000891	0.00125	CcSEcCtD
Methysergide—Fatigue—Paclitaxel—kidney cancer	0.000889	0.00125	CcSEcCtD
Methysergide—Diarrhoea—Vincristine—kidney cancer	0.000889	0.00124	CcSEcCtD
Methysergide—Asthenia—Gemcitabine—kidney cancer	0.000884	0.00124	CcSEcCtD
Methysergide—Myalgia—Capecitabine—kidney cancer	0.000883	0.00124	CcSEcCtD
Methysergide—Chest pain—Capecitabine—kidney cancer	0.000883	0.00124	CcSEcCtD
Methysergide—Arthralgia—Capecitabine—kidney cancer	0.000883	0.00124	CcSEcCtD
Methysergide—Constipation—Paclitaxel—kidney cancer	0.000882	0.00123	CcSEcCtD
Methysergide—Pain—Paclitaxel—kidney cancer	0.000882	0.00123	CcSEcCtD
Methysergide—Weight increased—Doxorubicin—kidney cancer	0.000873	0.00122	CcSEcCtD
Methysergide—Discomfort—Capecitabine—kidney cancer	0.000872	0.00122	CcSEcCtD
Methysergide—Weight decreased—Doxorubicin—kidney cancer	0.000868	0.00122	CcSEcCtD
Methysergide—Nausea—Dactinomycin—kidney cancer	0.000863	0.00121	CcSEcCtD
Methysergide—Dizziness—Vincristine—kidney cancer	0.000859	0.0012	CcSEcCtD
Methysergide—Drowsiness—Doxorubicin—kidney cancer	0.000856	0.0012	CcSEcCtD
Methysergide—Feeling abnormal—Paclitaxel—kidney cancer	0.00085	0.00119	CcSEcCtD
Methysergide—Oedema—Capecitabine—kidney cancer	0.000846	0.00119	CcSEcCtD
Methysergide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000843	0.00118	CcSEcCtD
Methysergide—Diarrhoea—Gemcitabine—kidney cancer	0.000843	0.00118	CcSEcCtD
Methysergide—Thrombocytopenia—Capecitabine—kidney cancer	0.000829	0.00116	CcSEcCtD
Methysergide—Tachycardia—Capecitabine—kidney cancer	0.000826	0.00116	CcSEcCtD
Methysergide—Vomiting—Vincristine—kidney cancer	0.000826	0.00116	CcSEcCtD
Methysergide—Rash—Vincristine—kidney cancer	0.000819	0.00115	CcSEcCtD
Methysergide—Dermatitis—Vincristine—kidney cancer	0.000818	0.00115	CcSEcCtD
Methysergide—Body temperature increased—Paclitaxel—kidney cancer	0.000815	0.00114	CcSEcCtD
Methysergide—Abdominal pain—Paclitaxel—kidney cancer	0.000815	0.00114	CcSEcCtD
Methysergide—Vomiting—Gemcitabine—kidney cancer	0.000783	0.0011	CcSEcCtD
Methysergide—Rash—Gemcitabine—kidney cancer	0.000777	0.00109	CcSEcCtD
Methysergide—Dermatitis—Gemcitabine—kidney cancer	0.000776	0.00109	CcSEcCtD
Methysergide—Nausea—Vincristine—kidney cancer	0.000771	0.00108	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000771	0.00108	CcSEcCtD
Methysergide—Insomnia—Capecitabine—kidney cancer	0.000766	0.00107	CcSEcCtD
Methysergide—Paraesthesia—Capecitabine—kidney cancer	0.00076	0.00106	CcSEcCtD
Methysergide—Oedema peripheral—Doxorubicin—kidney cancer	0.000757	0.00106	CcSEcCtD
Methysergide—Dyspnoea—Capecitabine—kidney cancer	0.000755	0.00106	CcSEcCtD
Methysergide—Dyspepsia—Capecitabine—kidney cancer	0.000745	0.00104	CcSEcCtD
Methysergide—Asthenia—Paclitaxel—kidney cancer	0.00074	0.00104	CcSEcCtD
Methysergide—Nausea—Gemcitabine—kidney cancer	0.000732	0.00102	CcSEcCtD
Methysergide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000731	0.00102	CcSEcCtD
Methysergide—Fatigue—Capecitabine—kidney cancer	0.00073	0.00102	CcSEcCtD
Methysergide—Pain—Capecitabine—kidney cancer	0.000724	0.00101	CcSEcCtD
Methysergide—Constipation—Capecitabine—kidney cancer	0.000724	0.00101	CcSEcCtD
Methysergide—Flushing—Doxorubicin—kidney cancer	0.000713	0.000998	CcSEcCtD
Methysergide—Diarrhoea—Paclitaxel—kidney cancer	0.000706	0.000988	CcSEcCtD
Methysergide—Feeling abnormal—Capecitabine—kidney cancer	0.000698	0.000977	CcSEcCtD
Methysergide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000692	0.000969	CcSEcCtD
Methysergide—Dizziness—Paclitaxel—kidney cancer	0.000682	0.000955	CcSEcCtD
Methysergide—Alopecia—Doxorubicin—kidney cancer	0.000679	0.00095	CcSEcCtD
Methysergide—Ergotamine—ABCB1—kidney cancer	0.000675	0.267	CrCbGaD
Methysergide—Abdominal pain—Capecitabine—kidney cancer	0.000669	0.000937	CcSEcCtD
Methysergide—Body temperature increased—Capecitabine—kidney cancer	0.000669	0.000937	CcSEcCtD
Methysergide—Vomiting—Paclitaxel—kidney cancer	0.000656	0.000918	CcSEcCtD
Methysergide—Bromocriptine—ABCB1—kidney cancer	0.000651	0.258	CrCbGaD
Methysergide—Rash—Paclitaxel—kidney cancer	0.00065	0.000911	CcSEcCtD
Methysergide—Dermatitis—Paclitaxel—kidney cancer	0.00065	0.00091	CcSEcCtD
Methysergide—Back pain—Doxorubicin—kidney cancer	0.000647	0.000905	CcSEcCtD
Methysergide—Ill-defined disorder—Doxorubicin—kidney cancer	0.00062	0.000868	CcSEcCtD
Methysergide—Nausea—Paclitaxel—kidney cancer	0.000613	0.000858	CcSEcCtD
Methysergide—Asthenia—Capecitabine—kidney cancer	0.000607	0.00085	CcSEcCtD
Methysergide—Malaise—Doxorubicin—kidney cancer	0.000603	0.000844	CcSEcCtD
Methysergide—Convulsion—Doxorubicin—kidney cancer	0.000579	0.000811	CcSEcCtD
Methysergide—Diarrhoea—Capecitabine—kidney cancer	0.000579	0.000811	CcSEcCtD
Methysergide—Myalgia—Doxorubicin—kidney cancer	0.000569	0.000797	CcSEcCtD
Methysergide—Arthralgia—Doxorubicin—kidney cancer	0.000569	0.000797	CcSEcCtD
Methysergide—Chest pain—Doxorubicin—kidney cancer	0.000569	0.000797	CcSEcCtD
Methysergide—Discomfort—Doxorubicin—kidney cancer	0.000562	0.000787	CcSEcCtD
Methysergide—Dizziness—Capecitabine—kidney cancer	0.00056	0.000784	CcSEcCtD
Methysergide—Oedema—Doxorubicin—kidney cancer	0.000546	0.000764	CcSEcCtD
Methysergide—Vomiting—Capecitabine—kidney cancer	0.000538	0.000754	CcSEcCtD
Methysergide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000534	0.000748	CcSEcCtD
Methysergide—Rash—Capecitabine—kidney cancer	0.000534	0.000747	CcSEcCtD
Methysergide—Dermatitis—Capecitabine—kidney cancer	0.000533	0.000747	CcSEcCtD
Methysergide—Tachycardia—Doxorubicin—kidney cancer	0.000533	0.000746	CcSEcCtD
Methysergide—Nausea—Capecitabine—kidney cancer	0.000503	0.000704	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000497	0.000696	CcSEcCtD
Methysergide—Insomnia—Doxorubicin—kidney cancer	0.000494	0.000691	CcSEcCtD
Methysergide—Paraesthesia—Doxorubicin—kidney cancer	0.00049	0.000686	CcSEcCtD
Methysergide—Dyspnoea—Doxorubicin—kidney cancer	0.000486	0.000681	CcSEcCtD
Methysergide—Somnolence—Doxorubicin—kidney cancer	0.000485	0.000679	CcSEcCtD
Methysergide—Dyspepsia—Doxorubicin—kidney cancer	0.00048	0.000672	CcSEcCtD
Methysergide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000471	0.00066	CcSEcCtD
Methysergide—Fatigue—Doxorubicin—kidney cancer	0.00047	0.000659	CcSEcCtD
Methysergide—Pain—Doxorubicin—kidney cancer	0.000467	0.000653	CcSEcCtD
Methysergide—Constipation—Doxorubicin—kidney cancer	0.000467	0.000653	CcSEcCtD
Methysergide—Feeling abnormal—Doxorubicin—kidney cancer	0.00045	0.00063	CcSEcCtD
Methysergide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000446	0.000625	CcSEcCtD
Methysergide—Abdominal pain—Doxorubicin—kidney cancer	0.000431	0.000604	CcSEcCtD
Methysergide—Body temperature increased—Doxorubicin—kidney cancer	0.000431	0.000604	CcSEcCtD
Methysergide—Asthenia—Doxorubicin—kidney cancer	0.000391	0.000548	CcSEcCtD
Methysergide—Diarrhoea—Doxorubicin—kidney cancer	0.000373	0.000523	CcSEcCtD
Methysergide—Dizziness—Doxorubicin—kidney cancer	0.000361	0.000505	CcSEcCtD
Methysergide—Vomiting—Doxorubicin—kidney cancer	0.000347	0.000486	CcSEcCtD
Methysergide—Rash—Doxorubicin—kidney cancer	0.000344	0.000482	CcSEcCtD
Methysergide—Dermatitis—Doxorubicin—kidney cancer	0.000344	0.000481	CcSEcCtD
Methysergide—Nausea—Doxorubicin—kidney cancer	0.000324	0.000454	CcSEcCtD
